| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/28/2023 |
SC 13G
| Polar Capital Holdings Plc reports a 5% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 07/13/2023 |
SC 13G/A
| Polar Capital Holdings Plc reports a 8.1% stake in Nanostring Technologies, Inc. |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G/A
| Polar Capital Holdings Plc reports a 0% stake in Summit Therapeutics Inc. |
| 02/14/2023 |
SC 13G
| Polar Capital Holdings Plc reports a 5.9% stake in Revance Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Polar Capital Holdings Plc reports a 0% stake in Quotient Limited |
| 02/14/2023 |
SC 13G
| Polar Capital Holdings Plc reports a 8.1% stake in Nanostring Technologies, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| Polar Capital Holdings Plc reports a 2.4% stake in Bellus Health Inc. |
| 02/14/2022 |
SC 13G/A
| Polar Capital Holdings Plc reports a 6.4% stake in Summit Therapeutics Inc. |
| 02/14/2022 |
SC 13G/A
| Polar Capital Holdings Plc reports a 9% stake in Quotient Limited |
| 02/14/2022 |
SC 13G/A
| Polar Capital Holdings Plc reports a 0% stake in Oxford Immunotec Global PLC |
| 02/14/2022 |
SC 13G
| Polar Capital Holdings Plc reports a 5.6% stake in Infinity Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Polar Capital Holdings Plc reports a 4.8% stake in AVADEL PHARMACEUTICALS PLC |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
SC 13G
| Polar Capital Holdings Plc reports a 5.2% stake in AVADEL PHARMACEUTICALS PLC |
| 02/16/2021 |
SC 13G/A
| Polar Capital Holdings Plc reports a 4.5% stake in Bellus Health Inc. |
| 02/16/2021 |
SC 13G/A
| Polar Capital Holdings Plc reports a 9.9% stake in Oxford Immunotec Global PLC |
| 02/16/2021 |
SC 13G/A
| Polar Capital Holdings Plc reports a 9.2% stake in Quotient Limited |
| 02/16/2021 |
SC 13G
| Polar Capital Holdings Plc reports a 7% stake in Summit Therapeutics Inc. |